Synthesis and biological evaluation of novel 2-arylamino-3-(arylsulfonyl)quinoxalines as PI3Kα inhibitors.
Wu P, Su Y, Liu X, Zhang L, Ye Y, Xu J, Weng S, Li Y, Liu T, Huang S, Yang B, He Q, Hu Y.
Wu P, et al. Among authors: liu x, liu t.
Eur J Med Chem. 2011 Nov;46(11):5540-8. doi: 10.1016/j.ejmech.2011.09.015. Epub 2011 Sep 17.
Eur J Med Chem. 2011.
PMID: 21945250